Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration. (2017)

First Author: Negm OH
Attributed to:  Structure-function studies on Clostridium difficile large toxins funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/cei.12946

PubMed Identifier: 28213939

Publication URI: http://europepmc.org/abstract/MED/28213939

Type: Journal Article/Review

Volume: 188

Parent Publication: Clinical and experimental immunology

Issue: 3

ISSN: 0009-9104